Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines-Reference-Cited by-同舟云学术

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines

Published:2022-01 Issue:1 Volume:10 Page:e142-e147
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Oliu-Barton Miquel,Pradelski Bary S R,Algan Yann,Baker Michael G,Binagwaho Agnes,Dore Gregory J,El-Mohandes Ayman,Fontanet Arnaud,Peichl Andreas,Priesemann Viola,Wolff Guntram B,Yamey Gavin,Lazarus Jeffrey V

Funder

Agence nationale de la recherche

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Elimination could be the optimal response strategy for COVID-19 and other emerging pandemic diseases;Baker;BMJ,2020

2. SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties;Oliu-Barton;Lancet,2021

3. SARS-CoV-2 incidence and vaccine escape;Thompson;Lancet Infect Dis,2021

4. Trust and compliance to public health policies in times of COVID-19;Bargain;J Public Econ,2020

5. In science we (should) trust: expectations and compliance across nine countries during the COVID-19 pandemic;Bicchieri;PLoS One,2021

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccines should be evaluated from the societal perspective;Journal of Medical Economics;2023-12-15

2. Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view;eClinicalMedicine;2023-10

3. Advancing the Management of Long COVID by Integrating into Health Informatics Domain: Current and Future Perspectives;International Journal of Environmental Research and Public Health;2023-09-26

4. Evaluating vaccine allocation strategies using simulation-assisted causal modeling;Patterns;2023-06

5. Biomimetic Nanovaccines: A Novel Approach in Immunization;Current Pharmaceutical Design;2023-05